Insights From Cardiovascular Outcome Trials with Novel Antidiabetes Agents: What Have We Learned? An Industry Perspective
Crossref DOI link: https://doi.org/10.1007/s11892-015-0663-9
Published Online: 2015-09-14
Published Print: 2015-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hirshberg, Boaz
Katz, Arie
Text and Data Mining valid from 2015-09-14